X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-11-08 | THRD | Conner Edward R. | Chief Medical Officer | S - Sale+OE | $15.00 | -2,117 | 0 | -100% | -$31,755 | |||||
2024-10-29 | THRD | Bvf Partners L P/Il | See Explanation of Responses | S - Sale | $14.30 | -1,000,000 | 176,692 | -85% | -$14,300,000 | ||||||
D | 2024-10-28 | THRD | Conner Edward R. | Chief Medical Officer | S - Sale+OE | $15.00 | -2,673 | 0 | -100% | -$40,095 | |||||
D | 2024-09-19 | THRD | Conner Edward R. | Chief Medical Officer | S - Sale+OE | $15.00 | -4,790 | 0 | -100% | -$71,850 | |||||
DM | 2024-09-18 | THRD | Person Julie | Chief Administrative Officer | S - Sale+OE | $14.27 | -10,000 | 0 | -100% | -$142,727 | |||||
D | 2024-06-26 | THRD | Person Julie | Chief Administrative Officer | S - Sale+OE | $12.46 | -10,000 | 0 | -100% | -$124,569 | |||||
D | 2024-06-07 | THRD | Dittman Jennifer | Chief Development Oper Officer | S - Sale+OE | $14.17 | -494 | 0 | -100% | -$7,000 | |||||
D | 2024-05-20 | THRD | Dittman Jennifer | Chief Development Oper Officer | S - Sale+OE | $14.00 | -1,042 | 0 | -100% | -$14,588 | |||||
D | 2024-05-16 | THRD | Dittman Jennifer | Chief Development Oper Officer | S - Sale+OE | $14.04 | -23,578 | 0 | -100% | -$331,066 | |||||
D | 2024-05-09 | THRD | Holles Natalie C. | CEO | S - Sale+OE | $12.18 | -20,222 | 1,218,836 | -2% | -$246,300 | |||||
D | 2024-04-11 | THRD | Holles Natalie C. | CEO | S - Sale+OE | $12.19 | -13,558 | 1,218,836 | -1% | -$165,214 | |||||
D | 2024-04-04 | THRD | Person Julie | Chief Administrative Officer | S - Sale+OE | $10.00 | -1,107 | 0 | -100% | -$11,070 | |||||
D | 2023-12-05 | THRD | Person Julie | Chief Administrative Officer | S - Sale+OE | $10.30 | -12,863 | 0 | -100% | -$132,484 | |||||
D | 2023-12-05 | THRD | Conner Edward R. | Chief Medical Officer | S - Sale+OE | $10.03 | -4,790 | 0 | -100% | -$48,062 | |||||
2022-12-20 | THRD | Bvf Partners L P/il | 10% | P - Purchase | $4.11 | +214,063 | 241,309 | +786% | +$879,499 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |